Recently recognized as Forbes 50 over 50, Liz is a highly regarded industry leader with extensive experience leading, building and growing organizations at Fortune 100 pharmaceutical companies before moving to a biotech company. Ms. Barrett has served as director and President and Chief Executive Officer of UroGen Pharma since January 2019. Prior to UroGen, Ms. Barrett was CEO of Novartis Oncology and a member of the Novartis Executive Committee. Prior to Novartis, Ms. Barrett served at Pfizer, Inc. in various leadership capacities, most recently as the Global President of Oncology. Before that, Liz lived in Europe and served as President of Global Innovative Pharma for Europe, President of the Specialty Care Business Unit for North America, and Regional President of United States Oncology. Ms. Barrett held positions at Cephalon, Inc., where she built then lead the Oncology Business Unit, and at Johnson & Johnson where she held many positions of increasing responsibility including head of the Oncology Business Unit. She spent the first 10 years of her career in the consumer sector. Ms. Barrett also currently serves on the boards of directors of Sage Therapeutics and Allogene Therapeutics. Ms. Barrett received an M.B.A. from Saint Joseph's University and a B.S. from the University of Louisiana.